Riskpilot← Back to searchSign inGet full accessCogito Med AB
ABActiveOrg 5592976210Havstenavägen 34 C Lgh 1101Hospital activities · NACE 8610Est. 20211 employees
Revenue 2025
SEK 72K
+208% vs 2024
EBITDA margin
9.1%
+109% vs 2024
Equity ratio
31.8%
Financial strength
Net profit 2025
SEK 856
-97% vs 2024
| Revenue | SEK 72K | +208% |
| EBITDA | SEK 7K | +109% |
| Net profit | SEK 856 | -97% |
| Total assets | SEK 264K | -14% |
| Equity | SEK 84K | +1% |
| Employees | 1 | — |
Legal name
Cogito Med AB
Org number
5592976210
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
20 januari 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanterna
Company purpose
Hälso- o sjukvård, utbildning, medicinsk forskning
Address
Havstenavägen 34 C Lgh 1101
Email
gunillalandgren@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 306 | 780 | 590 | 23 | 72 |
| Staff expenses | — | −48 | −47 | −45 | −30 |
| EBITDA | 190 | 500 | 305 | −69 | 7 |
| Depreciation & amort. | −49 | −54 | −54 | −54 | −56 |
| EBIT | 141 | 446 | 251 | −124 | −49 |
| Net financials | −5 | 0 | 3 | 1 | −0 |
| Profit before tax | 100 | 330 | 190 | 42 | 2 |
| Tax | −22 | −61 | −40 | −11 | −1 |
| Net profit | 78 | 269 | 150 | 31 | 1 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 389 | 717 | 834 | 306 | 264 |
| Equity | 103 | 302 | 202 | 83 | 84 |
| Long-term debt | 0 | — | 203 | 141 | 166 |
| Short-term debt | 250 | 263 | 213 | 30 | 14 |
| Total debt | 250 | 263 | 416 | 172 | 180 |
EBITDA margin
9.1%
This company
15.8%
Market median
-42% vs market
20212025
Equity ratio
31.8%
This company
38.2%
Market median
+17% vs market
20212025
Return on equity
1.0%
This company
18.4%
Market median
-95% vs market
20212025
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20212025
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20212025
Debt / equity
2.14×
This company
0.62×
Market median
-245% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GK Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cogito Med AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunilla Kristina Landgren | Chief Executive Officer | 0 companies |
| Karl Markus Landgren | Deputy Board Member | 0 companies |
| Karl Magnus Landgren | Chairman | 0 companies |
| Knut Olof Landgren | Deputy Board Member | 0 companies |
| Per Valdemar Landgren | Deputy Board Member | 0 companies |